A Phase I Study Of PV701 In Patients With Head And Neck Squamous Cell Carcinoma

Trial Profile

A Phase I Study Of PV701 In Patients With Head And Neck Squamous Cell Carcinoma

Discontinued
Phase of Trial: Phase I

Latest Information Update: 23 Jan 2013

At a glance

  • Drugs PV 701 (Primary)
  • Indications Head and neck cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 23 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 11 Aug 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top